BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29238047)

  • 21. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
    Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells.
    Wang SY; Chen B; Zhan YQ; Xu WX; Li CY; Yang RF; Zheng H; Yue PB; Larsen SH; Sun HB; Yang X
    J Hepatol; 2004 Aug; 41(2):267-73. PubMed ID: 15288476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
    Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ
    Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy.
    Jankowski K; Kucia M; Wysoczynski M; Reca R; Zhao D; Trzyna E; Trent J; Peiper S; Zembala M; Ratajczak J; Houghton P; Janowska-Wieczorek A; Ratajczak MZ
    Cancer Res; 2003 Nov; 63(22):7926-35. PubMed ID: 14633723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The epidermal growth factor receptor pathway mediates resistance to sequential administration of radiation and chemotherapy in primary human glioblastoma cells in a RAS-dependent manner.
    Chakravarti A; Chakladar A; Delaney MA; Latham DE; Loeffler JS
    Cancer Res; 2002 Aug; 62(15):4307-15. PubMed ID: 12154034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncogenic Met receptor induces cell-cycle progression in Xenopus oocytes independent of direct Grb2 and Shc binding or Mos synthesis, but requires phosphatidylinositol 3-kinase and Raf signaling.
    Mood K; Saucier C; Ishimura A; Bong YS; Lee HS; Park M; Daar IO
    J Cell Physiol; 2006 Apr; 207(1):271-85. PubMed ID: 16331688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A selective c-met inhibitor blocks an autocrine hepatocyte growth factor growth loop in ANBL-6 cells and prevents migration and adhesion of myeloma cells.
    Hov H; Holt RU; Rø TB; Fagerli UM; Hjorth-Hansen H; Baykov V; Christensen JG; Waage A; Sundan A; Børset M
    Clin Cancer Res; 2004 Oct; 10(19):6686-94. PubMed ID: 15475459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HGF protects corneal epithelial cells from apoptosis by the PI-3K/Akt-1/Bad- but not the ERK1/2-mediated signaling pathway.
    Kakazu A; Chandrasekher G; Bazan HE
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3485-92. PubMed ID: 15452053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sphingosine kinase activation regulates hepatocyte growth factor induced migration of endothelial cells.
    Duan HF; Wu CT; Lu Y; Wang H; Liu HJ; Zhang QW; Jia XX; Lu ZZ; Wang LS
    Exp Cell Res; 2004 Aug; 298(2):593-601. PubMed ID: 15265705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of c-Met/hepatocyte growth factor pathway in cholangiocarcinoma cell invasion and its therapeutic inhibition with small interfering RNA specific for c-Met.
    Leelawat K; Leelawat S; Tepaksorn P; Rattanasinganchan P; Leungchaweng A; Tohtong R; Sobhon P
    J Surg Res; 2006 Nov; 136(1):78-84. PubMed ID: 16950403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen modulation of prolactin gene expression requires an intact mitogen-activated protein kinase signal transduction pathway in cultured rat pituitary cells.
    Watters JJ; Chun TY; Kim YN; Bertics PJ; Gorski J
    Mol Endocrinol; 2000 Nov; 14(11):1872-81. PubMed ID: 11075818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of either phosphatidylinositol 3-kinase/Akt or the mitogen/extracellular-regulated kinase, MEK/ERK, signaling pathways suppress growth of breast cancer cell lines, but MEK/ERK signaling is critical for cell survival.
    Ripple MO; Kalmadi S; Eastman A
    Breast Cancer Res Treat; 2005 Sep; 93(2):177-88. PubMed ID: 16187238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HER kinase activation confers resistance to MET tyrosine kinase inhibition in MET oncogene-addicted gastric cancer cells.
    Bachleitner-Hofmann T; Sun MY; Chen CT; Tang L; Song L; Zeng Z; Shah M; Christensen JG; Rosen N; Solit DB; Weiser MR
    Mol Cancer Ther; 2008 Nov; 7(11):3499-508. PubMed ID: 18974395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ERK2 but not ERK1 mediates HGF-induced motility in non-small cell lung carcinoma cell lines.
    Radtke S; Milanovic M; Rossé C; De Rycker M; Lachmann S; Hibbert A; Kermorgant S; Parker PJ
    J Cell Sci; 2013 Jun; 126(Pt 11):2381-91. PubMed ID: 23549785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HGF-mediated apoptosis via p53/bax-independent pathway activating JNK1.
    Conner EA; Teramoto T; Wirth PJ; Kiss A; Garfield S; Thorgeirsson SS
    Carcinogenesis; 1999 Apr; 20(4):583-90. PubMed ID: 10223185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of sublethal concentrations of epidermal growth factor receptor inhibitor and microtubule stabilizer induces apoptosis of glioblastoma cells.
    Failly M; Korur S; Egler V; Boulay JL; Lino MM; Imber R; Merlo A
    Mol Cancer Ther; 2007 Feb; 6(2):773-81. PubMed ID: 17308073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocyte growth factor activates several transduction pathways in rat pancreatic acini.
    Aparicio IM; Garcia-Marin LJ; Andreolotti AG; Bodega G; Jensen RT; Bragado MJ
    Biochim Biophys Acta; 2003 Dec; 1643(1-3):37-46. PubMed ID: 14654226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth.
    Trusolino L; Bertotti A; Comoglio PM
    Cell; 2001 Nov; 107(5):643-54. PubMed ID: 11733063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma.
    Derksen PW; Keehnen RM; Evers LM; van Oers MH; Spaargaren M; Pals ST
    Blood; 2002 Feb; 99(4):1405-10. PubMed ID: 11830493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocyte growth factor and c-Met promote dendritic maturation during hippocampal neuron differentiation via the Akt pathway.
    Lim CS; Walikonis RS
    Cell Signal; 2008 May; 20(5):825-35. PubMed ID: 18262389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.